
Instem Reinforces Dedication to Comprehensive Preclinical Platform Amid Evolving Regulatory Landscape
Instem Reinforces Commitment to End-to-End Preclinical Solutions Amid Evolving Regulatory Landscape In response to the FDA’s recent announcement expanding flexibility in preclinical submission evidence, Instem, a global leader in life sciences technology, is reaffirming its position as the industry’s trusted…











